Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Survey reveals need for consensus on canine FMT
The survey demonstrated a wide variety of methods used for preparation, dosage and administration of FMT in dogs.
International survey demonstrates significant variety of methods used. 

An international survey of small animal veterinary surgeons has demonstrated a need for consensus and standard practices on canine gut bacteria transplants.

The survey, sent out by researchers at the the University of Edinburgh's Royal (Dick) School of Veterinary Studies, received responses from veterinary surgeons is 13 different countries, and highlighted variations in the way that the transplant is prepared for and donor is chosen, the amount of gut bacteria used, and the method of administration. 

Of the respondents, 71 per cent had never performed faecal microbiota transplantation (FMT). Of those who had, it was undertaken most often to manage long-term gastrointestinal disease – chronic enteropathy, and parvovirus infection. 

Responses also demonstrated that FMT was used as a therapy for Small Intestinal Bacterial Overgrowth (SIBO), bacterial infection, hemorrhagic gastroenteritis, and idiopathic diarrhoea in puppies. 

Respondents also reported using a variety of modes of administration, with enema being the most common, followed by endoscopically into the duodenum, endoscopically into the colon, endoscopically into the ileum, orally via naso-oesophagael or naso-gastric tube and other oral applications. 

Given the variety of methods demonstrated in the survey, researchers have established that a need for a consensus on standard practices to optimise the impact of FMT. 

Dr Silke Salavati, author of the observational study, and senior lecturer in Small Animal Internal Medicine at the Dick Vet, said: “Faecal microbiota transplantation holds great potential for alleviating serious complications that involve disturbances of the gut flora caused by drugs like antibiotics, but also for long-term gastrointestinal conditions in dogs, and is a relatively simple, inexpensive approach. 

“We hope our findings can help accelerate consensus in the vet community on how best to prepare, dose and administer this treatment, and inform donor selection, to support canine care and enable further research into the benefits of FMT.” 

The outcomes from the study will be used by veterinary professionals in the Companion Animal Faecal Bank Consortium to establish a protocol for preparation, dosing and administration of FMT in dogs. 

Published in Topics in Companion Animal Medicine, the observational study is available to read online free of charge. 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.